このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Zimmer Biomet Holdings マネジメント
マネジメント 基準チェック /34
Zimmer Biomet Holdings'の CEO はIvan Tornosで、 Mar2021年に任命され、 の在任期間は 3.25年です。 の年間総報酬は$ 10.19Mで、 9.5%給与と90.5%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.013%を直接所有しており、その価値は$ 2.86M 。経営陣と取締役会の平均在任期間はそれぞれ3.3年と7.7年です。
主要情報
Ivan Tornos
最高経営責任者
US$10.2m
報酬総額
| CEO給与比率 | 9.5% |
| CEO在任期間 | 3.3yrs |
| CEOの所有権 | 0.01% |
| 経営陣の平均在職期間 | 3.3yrs |
| 取締役会の平均在任期間 | 7.7yrs |
経営陣の近況
Recent updates
Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24
Jun 19
When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Jun 05Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24
May 21Zimmer Biomet Holdings: Moving Along
May 17The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising
May 02Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
Mar 20Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Mar 02Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality
Feb 15What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?
Feb 11Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
Feb 05A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Jan 29Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'
Jan 20Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar
Jan 15The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing
Dec 31Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution
Dec 18Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly
Dec 17Zimmer Biomet: Still Many Questions After A Solid Year So Far
Nov 26When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Nov 06Here's Why We Think Zimmer Biomet Holdings (NYSE:ZBH) Is Well Worth Watching
Oct 07Returns On Capital At Zimmer Biomet Holdings (NYSE:ZBH) Have Hit The Brakes
Sep 21Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence
Sep 14Calculating The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Sep 06Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy
Aug 11Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?
Aug 08Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
Jul 10We Ran A Stock Scan For Earnings Growth And Zimmer Biomet Holdings (NYSE:ZBH) Passed With Ease
Jun 27Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement
Jun 13A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
May 30Zimmer Biomet: Expect Growth Momentum To Continue
May 26Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
May 04At US$129, Is It Time To Put Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On Your Watch List?
Apr 02Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Appealing
Mar 13A Look At The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Feb 21Improving Ortho Performance At Zimmer Biomet Is Encouraging
Feb 09Zimmer Biomet Q4 2022 Earnings Preview
Feb 02We Think Zimmer Biomet Holdings (NYSE:ZBH) Can Stay On Top Of Its Debt
Jan 19Zimmer Biomet to acquire soft tissue healing company Embody
Jan 05Zimmer Biomet declares $0.24 dividend
Dec 15Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
Dec 03Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Could Be 26% Below Their Intrinsic Value Estimate
Nov 17CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$964m |
| Dec 31 2023 | US$10m | US$969k | US$1b |
| Sep 30 2023 | n/a | n/a | US$474m |
| Jun 30 2023 | n/a | n/a | US$506m |
| Mar 31 2023 | n/a | n/a | US$450m |
| Dec 31 2022 | US$6m | US$823k | US$290m |
| Sep 30 2022 | n/a | n/a | US$366m |
| Jun 30 2022 | n/a | n/a | US$334m |
| Mar 31 2022 | n/a | n/a | US$325m |
| Dec 31 2021 | US$5m | US$731k | US$445m |
| Sep 30 2021 | n/a | n/a | US$834m |
| Jun 30 2021 | n/a | n/a | US$914m |
| Mar 31 2021 | n/a | n/a | US$563m |
| Dec 31 2020 | US$4m | US$730k | -US$11m |
| Sep 30 2020 | n/a | n/a | -US$152m |
| Jun 30 2020 | n/a | n/a | US$37m |
| Mar 31 2020 | n/a | n/a | US$377m |
| Dec 31 2019 | US$4m | US$700k | US$1b |
| Sep 30 2019 | n/a | n/a | -US$90m |
| Jun 30 2019 | n/a | n/a | -US$359m |
| Mar 31 2019 | n/a | n/a | -US$308m |
| Dec 31 2018 | US$4m | US$113k | -US$379m |
報酬と市場: Ivanの 総報酬 ($USD 10.19M ) は、 US市場 ($USD 13.53M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Ivanの報酬は過去 1 年間で 20% 以上増加しました。
CEO（最高経営責任者
Ivan Tornos (49 yo)
3.3yrs
在職期間
US$10,191,476
報酬
Mr. Ivan Tornos serves as Independent External Director at PHC Holdings Corporation since September 03, 2021. He joined PHC Holdings Corporation on September 03, 2021. Mr. Tornos serves as Chief Operating...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| COO, President | 3.3yrs | US$10.19m | 0.013% $ 2.9m | |
| CFO and Executive VP of Finance | 4.9yrs | US$10.38m | 0.010% $ 2.2m | |
| Senior VP | 17.1yrs | US$2.87m | 0.024% $ 5.3m | |
| President of Asia Pacific | 9yrs | US$3.38m | 0.0026% $ 568.5k | |
| Group President of Europe | 3yrs | US$3.42m | 0.0035% $ 763.8k | |
| VP, Controller & Chief Accounting Officer | 2.1yrs | データなし | 0.00067% $ 147.1k | |
| Chief Science | 3yrs | データなし | データなし | |
| Senior VP and Chief Information & Digital Officer | less than a year | データなし | データなし | |
| Senior VP & Chief Administrative Officer | less than a year | データなし | 0.0033% $ 730.9k | |
| Director of Investor Relations | no data | データなし | データなし | |
| Senior VP | 9yrs | データなし | データなし | |
| Senior VP & Chief Human Resources Officer | 3.3yrs | データなし | 0.0016% $ 355.6k |
3.3yrs
平均在職期間
54yo
平均年齢
経験豊富な経営陣: ZBHの経営陣は 経験豊富 であると考えられます ( 3.3年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| COO, President | less than a year | US$10.19m | 0.013% $ 2.9m | |
| Independent Chairman of the Board | 11.9yrs | US$409.38k | 0.0017% $ 377.5k | |
| Independent Director | 15.4yrs | US$340.26k | 0.0026% $ 561.9k | |
| Independent Director | 16.3yrs | US$358.20k | 0.0019% $ 425.8k | |
| Independent Director | 17.3yrs | US$347.75k | 0.0016% $ 362.2k | |
| Director | less than a year | データなし | データなし | |
| Independent Director | 5.8yrs | US$314.44k | 0.00080% $ 175.6k | |
| Independent Director | 9.5yrs | US$342.52k | 0.00097% $ 212.9k | |
| Independent Director | 3.3yrs | US$382.35k | 0.00049% $ 107.6k | |
| Independent Director | 5.8yrs | US$367.52k | 0.0020% $ 432.4k |
7.7yrs
平均在職期間
62yo
平均年齢
経験豊富なボード: ZBHの 取締役会 は 経験豊富 であると考えられます ( 7.7年の平均在任期間)。